Atlas Trials

Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer

Clinical trial NCT04665986 · UNKNOWN

Trial details

NCT number
NCT04665986
Sponsor
Zhejiang Cancer Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2021-03-01
Primary completion
2022-02-28
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.